Astec Lifesciences (NSE:ASTEC) Short-Term Debt: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ASTEC Astec Lifesciences Ltd NSE:ASTEC
65 GF Score
Price ₹615.20
GF Value ₹817.44
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Astec Lifesciences Short-Term Debt?

Astec Lifesciences NSE:ASTEC -0.88% 65 Short-Term Debt is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:ASTEC with a GF Score™ of 65/100 and a GF Value™ of ₹817.44 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Astec Lifesciences's Short-Term Debt for the quarter that ended in Jun. 2026 was ₹0 Mil.

Astec Lifesciences's quarterly Short-Term Debt increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹3,989 Mil) but then declined from Mar. 2026 (₹3,989 Mil) to Jun. 2026 (₹0 Mil).

Astec Lifesciences's annual Short-Term Debt declined from Mar. 2024 (₹2,949 Mil) to Mar. 2025 (₹2,745 Mil) but then increased from Mar. 2025 (₹2,745 Mil) to Mar. 2026 (₹3,989 Mil).

Astec Lifesciences Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Astec Lifesciences Short-Term Debt Related Terms

Astec Lifesciences Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Astec Lifesciences's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Astec Lifesciences Short-Term Debt Chart

Astec Lifesciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,793.73 3,303.18 2,948.95 2,745.44 3,989.30

Astec Lifesciences Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 2,480.23 0.00 3,989.30 0.00
NSE:ASTEC
65GF Score
Astec Lifesciences Ltd NSE:ASTEC
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of ₹0 Mil mean?
Astec Lifesciences (NSE:ASTEC) has a Short-Term Debt of ₹0 Mil as of Jun. 2026.
Is Astec Lifesciences' Short-Term Debt too high?
Astec Lifesciences' current Short-Term Debt is ₹0 Mil. Overall, Astec Lifesciences has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Astec Lifesciences' Short-Term Debt compare to CTVA and CF?
Astec Lifesciences' Short-Term Debt of ₹0 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for an Agriculture company?
A good Short-Term Debt depends on the Agriculture industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Astec Lifesciences's current Short-Term Debt is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astec Lifesciences stock overvalued right now?
Based on GuruFocus' analysis, Astec Lifesciences (NSE:ASTEC) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹817.44, compared to a current price of ₹615.20 — trading 24.7% below its estimated fair value. The current Short-Term Debt is ₹0 Mil. Astec Lifesciences' overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Astec Lifesciences (NSE:ASTEC), the current Short-Term Debt is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Astec Lifesciences (NSE:ASTEC) Overvalued in 2026?

Based on GuruFocus' analysis, Astec Lifesciences stock appears to be undervalued. The current stock price of ₹615.20 is trading 24.7% below its estimated GF Value™ of ₹817.44. GuruFocus considers Astec Lifesciences to be Modestly Undervalued.

Key valuation signals for NSE:ASTEC:

  • Short-Term Debt: ₹0 Mil
  • GF Value™: ₹817.44 vs. price of ₹615.20 (24.7% below fair value)
  • GF Score™: 65/100 with 4 warning signs

No single metric tells the full story. See the NSE:ASTEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Astec Lifesciences Business Description

Other Exchanges 533138:India
Address Eastern Express Highway, Godrej One, 3rd Floor, Pirojshanagar, Vikhroli (East), Mumbai, MH, IND, 400 079
Astec Lifesciences Ltd manufactures & distributes a wide range of Agrochemical active ingredients and pharmaceutical intermediates. The company's products include agrochemicals, such as Triazole Fungicides, Herbicides, and Insecticides. The company is also into Intermediates & Specialty chemicals. Geographically, all the operations of the firm function through India; however, its products are sold in the Indian and overseas markets. It operates in the business segment of Agrochemicals and has a business presence in India and outside India.
65GF Score

Get the complete analysis for NSE:ASTEC

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹615.20
Price
₹817.44
GF Value